Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07512700 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia

Name: Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia — clinical trial record (NCT07512700)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorChinese PLA General Hospital

Started2025-09-01

View on ClinicalTrials.gov ↗

Chinese PLA General Hospital

193 trials monitored

See 4 trials at risk

Leukemia

2,553 trials monitored

See 134 trials at risk

This study is a multicenter, randomized, prospective Phase II clinical trial designed to compare the effectiveness of two treatment approaches for patients with acute monocytic leukemia.

Trial Details

NCT Number	NCT07512700
Lead Sponsor	Chinese PLA General Hospital Collaborators: Air Force Medical Center of PLA, PLA Strategic Support Force's Characteristic Medical Center
Conditions	Acute Monocytic Leukemia
Enrollment	204 participants
Start Date	2025-09-01
Primary Completion	2028-09-30 (estimated)
Study Completion	2029-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-06